Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schneider, Rebecca
NCT05248997: Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis	Completed	3	261	US	rimegepant 75 mg ODT, Matching placebo	Pfizer, Biohaven Pharmaceutical Holding Company Ltd.	Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps	03/24	04/24
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps	Recruiting	3	120	US	OPN-375	Optinose US Inc.	Bilateral Nasal Polyposis	03/26	03/26
NCT03508440: Intratympanic Steroid for Bell's Palsy	Completed	2/3	10	US	Intratympanic injection, Prednisone, Prednisolone	University of Missouri-Columbia	Bell's Palsy, Facial Nerve Paresis	11/22	06/23
AQUAX2, NCT05926765: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia	Recruiting	2	120	Europe, Canada, US	AAV2-hAQP1 Concentration 1, AAV2-hAQP1 Concentration 2, Placebo	MeiraGTx, LLC	Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands	07/25	07/25
RAPID, NCT04287621: Registry of Asthma Patients Initiating DUPIXENT®	Active, not recruiting	N/A	718	Europe, Canada, Japan, US	DUPIXENT®, dupilumab, REGN668, SAR231893	Regeneron Pharmaceuticals, Sanofi	Asthma	07/26	07/26